Abbott Laboratories (ABT)

108.83 +3.64 (+3.46%) At close: 4:03PM EDT

Abbott Laboratories

100 Abbott Park Road
Department 377 Building AP6A-1, Abbott park
North Chicago, IL 60064
United States
224 667 6100
http://www.abbott.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 107,000

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Miles D. White M.B.A.	Exec. Chairman	6.97M	32.02M	1955
Mr. Robert B. Ford	CEO, Pres, COO & Director	2.63M	N/A	1974
Mr. Daniel Gesua Sive Salvadori	Exec. VP of Nutritional Products	1.67M	3.24M	1979
Ms. Lisa D. Earnhardt	Exec. VP of Medical Devices	1.33M	N/A	1970
Mr. Robert E. Funck Jr.	Exec. VP of Fin. & CFO	N/A	N/A	1961

Amounts are as of 31 December 2019, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. Its Established Pharmaceutical Products segment offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptom; gynecological disorder; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Ménière's disease and vestibular vertigo; pain, fever, and inflammation; migraine; and anti-infective clarithromycin, as well as provides influenza vaccines and products that regulate physiological rhythm of the colon. The company's Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automates the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detects and measures infectious agents; cartridges for blood analysis; rapid diagnostics systems; molecular point-of-care testing for HIV, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test systems, as well as remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. Its Nutritional Products segment provides pediatric and adult nutritional products. The company's Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chronic pain and movement disorders. This segment also provides glucose and blood glucose monitoring systems. Abbott Laboratories has an agreement with Tandem Diabetes Care to develop and commercialize integrated diabetes solutions. The company was founded in 1888 and is headquartered in North Chicago, Illinois.

Corporate governance

Abbott Laboratories’s ISS governance QualityScore as of 9 December 2019 is 5. The pillar scores are Audit: 2; Board: 5; Shareholder rights: 7; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.